InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by Kaufmann Gunnar F., Directeur Scientifique. Director active across 1 company, notably Oncternal Therapeutics, Inc.. In total, 4 reports have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €8k. History available since 3 January 2022. The latest transaction was disclosed on 12 June 2023 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Kaufmann Gunnar F.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报4 总计
25,000 股@ US$0.349857.6% 占其流量Common StockSEC:0001209191-23-036994:0
标准退出：2023年9月10日 (T+90)
6,266 股@ US$1.0242.4% 占其流量Common StockSEC:0001209191-23-002030:0
43,125 股0Common StockSEC:0001209191-22-043738:0
29,867 股0Common StockSEC:0001209191-22-001972:0
4 条申报中的 4 条
About Kaufmann Gunnar F.
Gunnar F. Kaufmann is the Chief Scientific Officer at Oncternal Therapeutics, Inc. In this role, he oversees the company's research and development activities. His scientific expertise is essential to guide research initiatives and ensure innovation.
